These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26381661)

  • 1. Optimization of culture conditions for Gardnerella vaginalis biofilm formation.
    Machado D; Palmeira-de-Oliveira A; Cerca N
    J Microbiol Methods; 2015 Nov; 118():143-6. PubMed ID: 26381661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
    Machado A; Cerca N
    J Infect Dis; 2015 Dec; 212(12):1856-61. PubMed ID: 26080369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model.
    Alves P; Castro J; Sousa C; Cereija TB; Cerca N
    J Infect Dis; 2014 Aug; 210(4):593-6. PubMed ID: 24596283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
    Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
    Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth of Gardnerella vaginalis and Lactobacillus acidophilus in Sorbarod biofilms.
    Muli FW; Struthers JK
    J Med Microbiol; 1998 May; 47(5):401-5. PubMed ID: 9879940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species biofilms.
    Castro J; Cerca N
    Anaerobe; 2015 Dec; 36():56-9. PubMed ID: 26505928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment.
    Verstraelen H; Swidsinski A
    Curr Opin Infect Dis; 2013 Feb; 26(1):86-9. PubMed ID: 23221767
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Shang X; Bai H; Fan L; Zhang X; Zhao X; Liu Z
    Front Cell Infect Microbiol; 2024; 14():1387414. PubMed ID: 38751998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli and Enterococcus faecalis are able to incorporate and enhance a pre-formed Gardnerella vaginalis biofilm.
    Castro J; Machado D; Cerca N
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26782142
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Castro J; Rosca AS; Cools P; Vaneechoutte M; Cerca N
    Front Cell Infect Microbiol; 2020; 10():83. PubMed ID: 32195197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune components affect growth and virulence traits of bacterial-vaginosis-associated and non-bacterial-vaginosis-associated Gardnerella vaginalis strains similarly.
    Castro J; Jefferson KK; Cerca N
    Pathog Dis; 2018 Dec; 76(9):. PubMed ID: 30649289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.
    Hymes SR; Randis TM; Sun TY; Ratner AJ
    J Infect Dis; 2013 May; 207(10):1491-7. PubMed ID: 23431033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotypes and virulence factors of Gardnerella vaginalis isolated from cases of bacterial vaginosis.
    Udayalaxmi J; Bhat GK; Kotigadde S
    Indian J Med Microbiol; 2011; 29(2):165-8. PubMed ID: 21654113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of virulence factors & biotypes of
    Nisha K; Antony B; Udayalaxmi J
    Indian J Med Res; 2019 Jan; 149(1):57-61. PubMed ID: 31115376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors.
    Castro J; Machado D; Cerca N
    ISME J; 2019 May; 13(5):1306-1317. PubMed ID: 30670827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.
    Swidsinski A; Dörffel Y; Loening-Baucke V; Schilling J; Mendling W
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):41-6. PubMed ID: 20955467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Compounds against Gardnerella vaginalis Biofilms.
    Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
    PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
    Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
    Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity.
    Hooven TA; Randis TM; Hymes SR; Rampersaud R; Ratner AJ
    J Antimicrob Chemother; 2012 Dec; 67(12):2870-2. PubMed ID: 22855857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis.
    Verhelst R; Verstraelen H; Claeys G; Verschraegen G; Delanghe J; Van Simaey L; De Ganck C; Temmerman M; Vaneechoutte M
    BMC Microbiol; 2004 Apr; 4():16. PubMed ID: 15102329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.